Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on September 8, 2026

Sep. 8, 2026

Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel

Indeterminate GlobeNewswire

Sep. 8, 2026

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

Indeterminate GlobeNewswire

Sep. 8, 2026

Draganfly Selected for All Five Capability Streams of Canada’s New Defence Drone Initiative Marketplace

Indeterminate GlobeNewswire

Sep. 8, 2026

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Indeterminate GlobeNewswire

Sep. 8, 2026

A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

Indeterminate GlobeNewswire

Sep. 8, 2026

ZenaTech Plans Franchise Business Model for Drone as a Service Power Washing

Indeterminate GlobeNewswire

Sep. 8, 2026

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Indeterminate GlobeNewswire

Sep. 8, 2026

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Indeterminate GlobeNewswire

Sep. 8, 2026

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire

Sep. 8, 2026

Confused.com Partners with HUMAN Security to Protect Digital Customer Journeys in the Agentic Era

Indeterminate GlobeNewswire

Sep. 8, 2026

Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director

Indeterminate GlobeNewswire

Sep. 8, 2026

CPTx appoints Matt Kane as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Ibogaine and the Bicameral Mind: The Definitive Clinical and Cultural Guide to Ibogaine Publishes Today

Indeterminate GlobeNewswire

Sep. 8, 2026

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Collegium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire